quinazolines has been researched along with gw9662 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diggle, C; Holder, J; Lee, WC; Selby, PJ; Southgate, J; Stahlschmidt, J; Trejdosiewicz, LK; Varley, CL | 1 |
| Cross, W; Garthwaite, MA; Hinley, J; Southgate, J; Trejdosiewicz, LK; Varley, CL | 1 |
| Dong, F; Liu, X; Luan, C; Luan, S; Shao, H; Sun, C; Zhang, G | 1 |
3 other study(ies) available for quinazolines and gw9662
| Article | Year |
|---|---|
Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme.
Topics: Active Transport, Cell Nucleus; Adipocytes; Anilides; Animals; Blotting, Western; Cattle; Cell Differentiation; Cell Line; Cell Proliferation; Chromans; Enzyme Inhibitors; Epidermal Growth Factor; Epithelium; ErbB Receptors; Gene Expression Regulation; Humans; Immunoprecipitation; Ligands; Membrane Glycoproteins; Membrane Proteins; Microscopy, Fluorescence; Phosphorylation; PPAR gamma; Promoter Regions, Genetic; Quinazolines; Ribonucleases; RNA, Messenger; Signal Transduction; Thiazolidinediones; Time Factors; Troglitazone; Uroplakin Ia; Uroplakin Ib; Uroplakin II; Uroplakin III; Urothelium | 2004 |
PPARgamma-regulated tight junction development during human urothelial cytodifferentiation.
Topics: Anilides; Benzamides; Calcium; Cell Culture Techniques; Cell Differentiation; Cells, Cultured; Claudin-1; Claudin-3; Claudin-4; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Humans; Membrane Proteins; Phosphoproteins; PPAR gamma; Proteasome Endopeptidase Complex; Pyridines; Quinazolines; Thiazolidinediones; Tight Junctions; Ureter; Urothelium; Zonula Occludens-1 Protein | 2006 |
Evodiamine inhibits the proliferation of leukemia cell line K562 by regulating peroxisome proliferators-activated receptor gamma (PPARĪ³) pathway.
Topics: Anilides; Apoptosis; Cell Cycle; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Gene Expression Regulation, Neoplastic; Humans; K562 Cells; Leukemia; PPAR gamma; Quinazolines | 2016 |